title: U.S. Selected Practice Recommendations for Contraceptive Use, 2016.
abstract: The 2016 U.S. Selected Practice Recommendations for Contraceptive Use (U.S. SPR) addresses a select group of common, yet sometimes controversial or complex, issues regarding initiation and use of specific contraceptive methods. These recommendations for health care providers were updated by CDC after review of the scientific evidence and consultation with national experts who met in Atlanta, Georgia, during August 26-28, 2015. The information in this report updates the 2013 U.S. SPR (CDC. U.S. selected practice recommendations for contraceptive use, 2013. MMWR 2013;62[No. RR-5]). Major updates include 1) revised recommendations for starting regular contraception after the use of emergency contraceptive pills and 2) new recommendations for the use of medications to ease insertion of intrauterine devices. The recommendations in this report are intended to serve as a source of clinical guidance for health care providers and provide evidence-based guidance to reduce medical barriers to contraception access and use. Health care providers should always consider the individual clinical circumstances of each person seeking family planning services. This report is not intended to be a substitute for professional medical advice for individual patients. Persons should seek advice from their health care providers when considering family planning options.
authors.affiliation: Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion.
authors.forename: Kathryn M
authors.initials: KM
authors.lastname: Curtis
authors.forename: Tara C
authors.initials: TC
authors.lastname: Jatlaoui
authors.forename: Naomi K
authors.initials: NK
authors.lastname: Tepper
authors.forename: Lauren B
authors.initials: LB
authors.lastname: Zapata
authors.forename: Leah G
authors.initials: LG
authors.lastname: Horton
authors.forename: Denise J
authors.initials: DJ
authors.lastname: Jamieson
authors.forename: Maura K
authors.initials: MK
authors.lastname: Whiteman
mesh_terms: D002487:Centers for Disease Control and Prevention, U.S.; D003267:Contraception / Q000379:methods*; D003270:Contraceptive Agents / Q000627:therapeutic use*; D003273:Contraceptive Devices / Q000009:adverse effects / Q000706:statistics & numerical data*; D005260:Female; D006801:Humans; D008297:Male; D017410:Practice Guidelines as Topic; D011247:Pregnancy; D014481:United States
chemical_list: D003270:Contraceptive Agents